Technology Behind
Innova Pure® delivers 99.5% pure CoQ10 in an amorphous state with isotropic characteristics, offering thermodynamic stability and strong resistance to photodegradation.
The formula uses targeting peptides for intracellular delivery, relying on affinity-based mechanisms to allow CoQ10 and other active ingredients to cross cellular barriers and be actively transported to the mitochondria.
A liposomal carrier system, enhanced with a modified polymeric surface, increases the solubility of lipophilic CoQ10, improving absorption through the gastrointestinal portal blood route.
A patented dual-ligand technology ensures targeted delivery to the heart, by binding to myocardial receptors for precise cardiac nutrient delivery
Key Challenges
INNOVA Pure® CoQ10 enhanced stability by provides purity, thermostability, and UV-resistant properties, overcoming degradation issues.
LipoXTEND® liposomes enhance bioavailability ensure superior absorption and protect actives from gastrointestinal degradation.
INNOVA Pure® CoQ10 has been engineered into an amorphous form to improve solubility and bioavailability.
Sustained-release mechanisms in LipoXTEND® maintain therapeutic nutrient levels over time.
Innova Pure® CoQ10 Advanced Formulation
-
Innova Pure® CoQ10 is developed using an amorphous structure that significantly enhances its solubility, stability, and absorption compared to standard CoQ10.
-
The formulation is designed to resist photodegradation and heat breakdown, offering superior protection and effectiveness under various environmental conditions.
Targeted Delivery & Protection Technologies
- MitoDrone® Technology uses mitochondria-specific ligands like TPP and MTP peptides to direct nutrients precisely to energy-producing mitochondria, improving cellular uptake.
- LipoXTEND® Technology incorporates liposomal encapsulation and a polymeric shell, safeguarding CoQ10 through digestion and ensuring sustained release and enhanced absorption in the body.
- Cardiodrone® Technology cardiac-specific ligands that guide liposomal payloads directly to myocardial cells through receptor-ligand interactions This targeted delivery system reduces systemic dilution by up to 75% for enhanced treatment effectiveness.
Mechanism of Action
The INNOVASOME® system enhances supplement effectiveness through targeted delivery, cellular penetration, and sustained release. It begins with mitochondria-specific ligands that guide the liposomal payload directly to cardiac mitochondria, where absorption occurs through receptor-mediated uptake or membrane potential-driven localization. The LipoXTEND® technology improves intracellular delivery by helping liposomes cross cell membranes efficiently, while its polymeric coating protects the payload from enzymatic breakdown. This advanced structure also enables a controlled, sustained release of Innova Pure® CoQ10, extending nutrient availability in the bloodstream and supporting consistent therapeutic effects with fewer doses.
Advanced Stability with Innova Pure® CoQ10
Thermostable, UV-resistant amorphous structure ensures 2x longer shelf life, 90% less degradation, and consistent potency even in harsh or challenging conditions.
Precision Targeting with MitoDrone® &Cardiodrone®
TPP peptides and Dual-Ligands target CoQ10 to cardiac mitochondria, increasing CoQ10 5x, ATP 300%, enhancing uptake and reducing efflux by 70%.
Enhanced Absorption with LipoXTEND® Delivery
Liposomal encapsulation with polymeric wax shell protects CoQ10, enabling 4x bioavailability, 85% absorption, and extended plasma retention for 6–8 hours.
Pharmacokinetics
INNOVASOME® CoQ10 advanced Targeting Technologies and LipoXTEND® Polymeric Surface Technologies to dramatically improve the pharmacokinetics of active ingredients delivered to the heart tissues.
• The INNOVASOME® CoQ10 form shows a higher and faster absorption, reaching a peak level of around 4.5 mg/L at 8 hours.
• The non-liposomal form shows a significantly lower absorption, peaking at around 1.2 mg/L at 8 hours.